Literature DB >> 9504715

Dipeptidyl peptidase IV in C6 rat glioma cell line differentiation.

A Sedo1, R Malík, E Krepela.   

Abstract

The C6 rat glioma cell line is broadly used as a model in studies of glial cell differentiation. In the present study we demonstrated a significantly higher total cellular, but especially membrane-associated, activity of dipeptidyl peptidase IV in differentiated C6 cells in comparison with their proliferating counterparts. The majority, but not all, of enzyme isoelectric focusing isoforms from differentiated C6 cells displayed a substantially higher activity compared to the proliferating cells, with G-P-NHMec as the substrate. Non-denaturing polyacrylamide gradient gel electrophoresis showed the presence of one major peak of activity, dipeptidyl peptidase IV (Mr of about 220000), in both proliferating and differentiated C6 cells. The results indicate that dipeptidyl peptidase IV regulation is associated with C6 rat glioma cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504715     DOI: 10.1515/bchm.1998.379.1.39

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-α in transformed astrocytic cells.

Authors:  Eva Balaziova; Petr Busek; Jarmila Stremenova; Lucie Sromova; Evzen Krepela; Libuse Lizcova; Aleksi Sedo
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

2.  Quaternary benzo[c]phenanthridine alkaloids as inhibitors of aminopeptidase N and dipeptidyl peptidase IV.

Authors:  Aleksi Sedo; Kvetoslava Vlasicová; Petr Barták; Radim Vespalec; Jaroslav Vicar; Vilim Simánek; Jitka Ulrichová
Journal:  Phytother Res       Date:  2002-02       Impact factor: 5.878

3.  The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort.

Authors:  Gilberto Vargas-Alarcón; María Del Carmen González-Salazar; Christian Vázquez-Vázquez; Adrián Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Juan Reyes-Barrera; Sergio A Criales-Vera; Marco Sánchez-Guerra; Citlalli Osorio-Yáñez; Rosalinda Posadas-Sánchez
Journal:  Front Genet       Date:  2021-06-11       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.